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Commentary on Evans et al. (2020): The complex
interplay between adolescent substance use, internalizing
and externalizing symptoms
The dynamic continuum between internalizing and
externalizing symptoms could explain the complex
association between specific emotional and behavioural
problems and adolescent substance use.
Evans and colleagues [1] found that adolescents who
presented more psychosomatic symptoms had higher odds
of alcohol and polysubstance use. The authors highlight
that throughout the study period this association remained
stable, and intervention strategies that address both
adolescent substance use and psychosomatic problems
may be appropriate.
Substance use in adolescence does not occur in
isolation. It co-occurs with other risk behaviours, such
as antisocial and risky sexual behaviours [2]. The origins
of these behaviours are multi-factorial and influenced
by socio-demographic, family and individual factors,
including common genetic and psychological vulnerabilities
[3]. The complex interplay between these factors and
the environment creates a developmental cascade that
originates in early childhood, shaping behaviour throughout
the life-span.
Emotional and behavioural symptoms—including
externalizing, internalizing and psychosomatic problems—
develop early in life and have been consistently associated
with adolescent risk behaviours [4,5]. There is strong
evidence for the association between externalizing
symptoms and adolescent substance use [6,7]. These
behaviours include conduct problems, hyperactivity,
impulsivity and inattention, each of which contributes to
a direct vulnerability to substance use early in life. This
association may stem from high levels of risk-taking
and low inhibitory control, both of which are common
in externalizing problems, negatively impacting on
decision-making processes [8].
However, for internalizingand psychosomatic symptoms,
the evidence for the association with adolescent substance
use is more scarce. A systematic review of the longitudinal
association between internalizing symptoms and substance
use in adolescence yielded mixed findings [9]. While
depressive symptoms often constituted a vulnerability for
later substance use, anxiety and internalizing symptoms
were not as clearly associated with later substance use [9].
The dichotomization between externalizing and
internalizing symptomsmay be artificial, due to the dynamic
relationship between these two constructs. Comorbidity
between internalizing and externalizing symptoms is quite
common, with higher levels of emotional problems tending
to cluster with conduct problems [10]. The combined
presentation of internalizing and externalizing symptoms is
associated with worse functional outcomes and substance
use in adolescence, translating into higher vulnerability for
risk behaviours [11].
It is also worth noting that profiles of emotional
and behavioural symptoms are not static throughout
development. While some children and adolescents will
develop only transient symptoms throughout development,
others will manifest chronic and stable emotional and
behavioural symptoms [12]. Additionally, children and
adolescents can present the same type (homotypical
continuity) or different types of problems (heterotypical
continuity) throughout development [13]. Thus, an
individual with externalizing problems in childhood can
present in adolescence with predominantly internalizing
problems, and vice-versa. The dynamic continuumbetween
internalizing and externalizing symptoms could explain
the complex association between specific emotional and
behavioural problems and adolescent substance use.
In this manner, interventions on the treatment and
prevention of adolescent substance use and other risk
behaviours should address externalizing and internalizing
symptoms jointly. As the first signs of internalizing and
externalizing symptoms usually appear in childhood—well
before the initiation of substance use in adolescence—
these interventions must be developmentally sensitive
and implemented as early as possible. Examples of these
interventions are parent-training programmes and the
psychological and medical treatment of emotional and
behavioural symptoms in children and adolescents. For
instance, Familias Unidas, a parent training programme
for Hispanic adolescents, has been shown to reduce both
externalizing and internalizing problems, and substance
use and other risk behaviours [14,15]. Similarly, the
treatment of attention-deficit/hyperactivity disorder with
psychostimulants has been associated with a lower risk
for alcohol and substance use in adolescents [16].
As Evans and colleagues emphasized, prevention and
intervention endeavours that address both psychosomatic
problems and adolescent substance use are crucial.
Further studies are needed to explore the hypothesis that
early treatment and prevention of internalizing and
externalizing symptoms in childhood prevents substance
use and other risk behaviours in adolescence.
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